- Timetable
- Download all abstracts
- Plenary Lectures
- MSSJ Special Program
- Award Lecture
- Symposium Sessions（Day1, Day2）
- Fundamental Sessions（Day1, Day3）
- Young Researchers' Sessions (Int'l)（Day1, Day3）
- Young Researchers' Sessions（Day1, Day3）
- Poster Presentations（Day1, Day2, Day3）
- Evening Workshop
- Corporate Program
Poster Presentations
Day 2, June 11（Tue.） Room P1 (Multipurpose Hall)・Room P2 (Conference Room 101+102)
- 2P-24
Structural Confirmation of Polyoxazoline-Conjugated Albumin as New Artificial Blood
(1Shimadzu, 2Chuo Univ.)
oTakashi Nishikaze1, Yuzo Yamazaki1, Teruyuki Komatsu2
The medical demand for animals, especially those kept as pets, is increasing year by year, but the infrastructure for blood transfusion therapy remains inadequate. Recently, we (Komatsu Lab team, Chuo University) have developed a new artificial blood product (artificial plasma) for pets “polyoxazoline (POx) conjugated albumin.” This formulation is created by chemical modification of readily available porcine-derived albumin (PSA) with POx and can be safely administered to dogs and cats. In this study, we present an example of the structural confirmation of POx-PSA using a matrix-assisted laser desorption/ionization time of flight mass spectrometer (MALDI-TOF MS).